Today Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of MyLab
“Accuracy and precision across the entire image generation chain, data processing speed and native AI-based application management lie at the heart of MyLab
MyLab
MyLab
“We are highly satisfied with this outcome, the result of substantial investment and intense work on R&D. The new MyLab
For its world premiere Esaote selected Manama, an international context and a vibrant multicultural hub. The event, that will be attended by the Bahraini authorities and by international clinical experts will be livestreamed on Esaote LinkedIn page (https://www.linkedin.com/events/mylab-x90livestreaming-a-i-augm7021420599726026753/) and will then be available on demand at mylabx90.com .
The new MyLab
510(k) pending at FDA, not available for sale in USA.
Esaote:
The Esaote Group, which last year celebrated 40 years of activity, is a leader in the biomedical equipment sector, in particular in the areas of ultrasound, magnetic resonance imaging and software for managing the diagnostic process. At the end of 2021, the Group had 1,280 employees, more than half of whom were in Italy. With headquarters in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in 100 countries around the world. www.esaote.com
SOURCE Esaote S.p.A.
Got a Questions?
Find us on Socials or Contact us and we’ll get back to you as soon as possible.